Hypertrophic eosinophilic gastroenteropathy is associated with reduced enterocyte apoptosis

R Cuperus1, M G Schäppi, N Shah

  • 1Gastroenterology, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Histopathology
|January 20, 2005
PubMed

Insights

A novel form of eosinophilic gastroenteropathy caused grossly elongated intestinal villi in children. This condition was linked to a lack of enterocyte apoptosis, leading to significant villous hyperplasia.

Area of Science:

  • Gastroenterology
  • Pediatric Pathology
  • Cell Biology

Background:

  • Eosinophilic gastroenteropathy (GE) is a rare disorder characterized by gastrointestinal tract infiltration with eosinophils.
  • A novel GE variant presented with severe intestinal villous hyperplasia, increased villous/crypt ratio, and mucosal eosinophilia in four children.
  • Affected children exhibited intermittent diarrhea and protein-losing enteropathy, suggesting significant malabsorption.

Observation:

  • The study investigated enterocyte proliferation, survival, and apoptosis in affected children and controls.
  • Key markers assessed included Ki67 for proliferation, bcl-2 for survival, and TUNEL for apoptosis.
  • A striking observation was the complete absence of detectable apoptotic enterocytes within the elongated villi.

Findings:

  • Enterocyte apoptosis was undetectable in the hyperplastic villi of children with this novel eosinophilic gastroenteropathy.
  • While enterocyte proliferation (Ki67) and survival factors (bcl-2) were assessed, the primary finding related to the lack of cell death.
  • This suggests a critical defect in programmed cell death regulation within the intestinal epithelium.

Implications:

  • The findings suggest that a defect in the regulation of epithelial apoptosis is the likely cause of the observed villous hyperplasia.
  • Understanding this mechanism could lead to targeted therapies for this severe form of eosinophilic gastroenteropathy.
  • Further research into the molecular pathways governing enterocyte apoptosis is warranted to elucidate the pathogenesis.
Abstract

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...